Effect of a hydrophilic formulation of topical paromomycin on cutaneous leishmaniasis among patients with contraindications for treatment with pentavalent antimonials;Efeito de uma formulação hidrofílica de paromomicina tópica na leishmaniose cutânea em pacientes com contra-indicações de tratamento com antimonial pentavalente

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 5, 2008, Pages 444-448

  Dos Santos, Aline Marques ^a   Noronha, Elza Ferreira ^a   Ferreira, Lucas Antônio Miranda ^b   Carranza Tamayo, César Omar ^a   Cupolillo, Elisa ^c   Romero, Gustavo Adolfo Sierra ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cutaneous leishmaniasis; Leishmania braziliensis; Paromomycin; Topical treatment

Indexed keywords

MEGLUMINE ANTIMONATE; PAROMOMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG EFFECT; EPITHELIZATION; FEMALE; HUMAN; LEISHMANIN SKIN TEST; MALE; SKIN LEISHMANIASIS; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PAROMOMYCIN; TREATMENT OUTCOME; YOUNG ADULT;

LEISHMANIA BRAZILIENSIS;

EID: 56549101670     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000500002     Document Type: Article

References (25)

1. Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Tropica 91:153-160, 2004.
2. Asilian A, Jalayer T, Whitwortth JAG, Ghasemi RL, Nilforooshzadeh M, Olliaro P. A randomized, placebo-controlled trial of two-week regimen of aminosidine (paramomycin) ointment for treatment of cutaneous leishmaniasis in Iran. The American Journal of Tropical Medicine and Hygiene 53: 648-651,1995.
3. Bryceson ADM, Murphy A, Moody AH. Treatment of Old-World cutaneous leishmaniasis with aminosidine ointment - results of an open study in London. Transactions of the Royal Society of Tropical Medicine and Hygiene 88: 226-228, 1994.
4. Carter KC, Alexander J. Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methylbenzetonium chloride and the aminoglycosides, gentamicin and paramomycin. Annals of Tropical Medicine and Parasitology 83: 233-239, 1989.
5. Correia D, Macêdo VO, Carvalho EM, Barral A, Magalhães AV, Abreu MV, Orge ML, Marsden P. Comparative study of meglumine antimoniate, pentamidine isethionate and aminosidine sulfate in the treatment of primary skin lesions caused by Leishmania (Viannia) braziliensis. Revista da Sociedade Brasileira de Medicina Tropical 29: 447-453, 1996.
6. Cupolillo E, Grimaldi Jr G, Momen H. A general classification of New World Leishmania using numerical zymotaxonomy. The American Journal of Tropical Medicine and Hygiene 50: 296-311, 1994.
7. Deps PD, Viana MC, Falqueto A, Dietze R. Comparative assessment of the efficacy and toxicity of N-methyl-glucamine and BP88 sodium stibogluconate in the treatment of localized cutaneous leishmaniasis. Revista da Sociedade Brasileira de Medicina Tropical 33: 535-543, 2000.
8. El-On J, Hamburguer AD. Topical treatment of New and Old World cutaneous leishmaniasis in experimental animals. Transactions of the Royal Society of Tropical Medicine and Hygiene 81: 734-737, 1987.
9. El-On J, Jacobs GP, Witztum E, Creenblat CL. Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals. Antimicrobial Agents and Chemotherapy 26: 745-751, 1984.
10. Fernandes AP, Carvalho FA, Tavares CA, Santiago HC, Castro GA, Tafuri WL, Ferreira LA. Combined interleukin-12 and topical chemotherapy for established leishmaniasis drastically reduces tissue parasitism and relapses in susceptible mice. Journal of Infectious Diseases 183: 1646-1652, 2001.
11. Gomes SFO, Nunan EA, Ferreira LAM. Emulsões múltiplas A/O/A contendo paromomicina para o tratamento tópico da leishmaniose cutânea: obtenção, caracterização e estabilidade. Revista Brasileira de Ciências Farmacêuticas 36: 277-284, 2000.
12. Gonçalves GS, Fernandes AP, Souza RCC, Cardoso JE, Silva FO, Maciel FC, Rabello A, Ferreira LAM. Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis. Acta Tropica 93: 161-167, 2005.
13. Grogl M, Schuster BG, Ellis WY, Berman JD. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (aminosidine) and gentamicin. Journal of Parasitology 85: 354-359, 1999.
14. Krause G, Kroeger A. Topical treatment of American cutaneous leishmaniasis with paromomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Transactions of the Royal Society of Tropical Medicine and Hygiene 88: 92-94, 1994.
15. Neva FA, Ponce C, Ponce E, Kreutzer R, Modabber F, Olliaro P. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin. Transactions of the Royal Society of Tropical Medicine and Hygiene 91: 473-475, 1997.
16. Romero GAS, Guerra MV, Paes MG, Cupolillo E, Toaldo CB, Macêdo VO, Fernandes O. Sensitivity of the polymerase chain reaction for the diagnosis of cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis. Acta Tropica 79: 225-229, 2001.
17. Romero GAS, Guerra MVF, Paes MG, Macedo VO. Comparison of cutaneous Leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate. The American Journal of Tropical Medicine and Hygiene 65: 456-465, 2001.
18. Romero GAS, Lessa HA, Macêdo VO, Carvalho EM, Barral A, Magalhães AV, Orge MG, Abreu MV, Marsden PD. Open therapeutic study with aminosidine sulfate in mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis Revista da Sociedade Brasileira de Medicina Tropical 29: 557-565, 1996.
19. Romero GAS, Sampaio RNR, Macêdo VO, Marsden PD. Sensitivity of lymph node aspiration in localized cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis. Memórias do instituto Oswaldo Cruz 94: 509-511, 1999.
20. Salah AB, Zakraqui H, Zaatour A, Ftaiti A, Zaafouri B, Garraoui A, Olliaro PL, Dellagi K, Ismail RB. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. The American Journal of Tropical Medicine and Hygiene 53: 162-166, 1995.
21. Saldanha AC, Romero GA, Guerra C, Merchan-Hamann E, Macedo VO. Comparative study between sodium stibogluconate BP 88 and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity. Revista da Sociedade Brasileira de Medicina Tropical 33: 383-388, 2000.
22. Soto J, Fuya P, Herrera R, Berman J. Topical paromomycin/ methylbenzethonium chloride plus parenteral meglumine antimoniate as treatment for American cutaneous leishmaniasis: controlled study. Clinical Infectious Diseases 26: 56-58, 1998.
23. Soto J, Hernandez N, Mejia H, Grogl M, Berman J. Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonite. Clinical Infectious Diseases 20: 47-51, 1995.
24. Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK. Injectable paromomycin for visceral leishmaniasis in India. New England Journal of Medicine 356: 2571-2581, 2007.
25. Teixeira AC, Paes MG, Guerra JO, Prata A, Silva-Vergara ML. Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil. Revista do Instituto de Medicina Tropical de São Paulo 49: 235-238, 2007.